Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects

British Journal of Radiology

Volumn 86, Issue 1029, 2013, Pages

  Fraioli, F ^a   Anzidei, M ^b   Serra, G ^b   Liberali, S ^b   Fiorelli, A ^b   Zaccagna, F ^b   Longo, F ^b   Anile, M ^b   Catalano, C ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; IOMEPROL; NAVELBINE; PACLITAXEL; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PLATINUM DERIVATIVE;

ADULT; AGED; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CANCER CHEMOTHERAPY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PERFUSION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; TREATMENT RESPONSE; TUMOR VOLUME; ADENOCARCINOMA; LARGE CELL CARCINOMA; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLATINUM COMPOUNDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84883038834     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20120174     Document Type: Article

References (22)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6. (Pubitemid 20020880)
2. Fontanini G, Vignati S, Boldrini L, Chinè S, Silvestri V, LucchiM, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997;3: 861-5. (Pubitemid 27252933)
3. Mattern J, Koomagi R, Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int J Oncol 1995;6:1059-62.
4. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, et al. Paclitaxel- carboplatin alone or with bevacizumab for nonsmall- cell lung cancer. N Engl J Med 2006;355: 2542-50. doi: 10.1056/NEJMoa061884 (Pubitemid 44917502)
5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32. doi: 10.1056/NEJMoa050753 (Pubitemid 41058344)
6. World Health Organization. WHO handbook for reporting results of cancer treatment. Offset Publication No.48. pp. 1-42. Geneva, Switzerland: World Health Organization; 1979. Available from http://whqlibdoc.who.int/offset/WHO-OFFSET- 48.pdf
7. Therasse P, Arbuck SG, Eisenhaueer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
8. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2:727-39. doi: 10.1038/nrc905 (Pubitemid 37328908)
9. Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, et al. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 2003;21:4428-38. doi: 10.1200/JCO.2003.12.986 (Pubitemid 46621821)
10. Yi CA, Lee KS, Kim EA, Han J, Kim H, Kwon OJ, et al. Solitary pulmonary nodules: dynamic enhanced multidetector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004;233:191-9. doi: 10.1148/radiol.2331031535 (Pubitemid 39280974)
11. Ma SH, Le HB, Jia BH, Wang ZX, Xiao ZW, Cheng XL, et al. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression. BMC Cancer 200830;8:186. doi: 10.1186/1471- 2407-8-186
12. Feng ST, Sun CH, Li ZP, Mak HK, Peng ZP, Guo HY, et al. Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging. Eur J Radiol 2010;75:191-6. doi: 10.1016/j. ejrad.2009.04.058
13. Goh V, Halligan S, Daley F, Wellsted DM, Guenther T, Bartram CI. Colorectal tumor vascularity: quantitative assessment with multidetector CT-do tumor perfusion measurements reflect angiogenesis? Radiology 2008;249:510-17. doi: 10.1148/radiol.2492071365
14. Ng QS, Goh V, Klotz E, Fichte H, Saunders MI, Hoskin PJ, et al. Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol 2006;187:1079-84. doi: 10.2214/AJR.05.0889 (Pubitemid 44453967)
15. Ng QS, Goh V, Fichte H, Klotz E, Fernie P, Saunders MI, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology 2006;239:547-53. doi: 10.1148/radiol. 2392050568
16. Park MS, Klotz E, Kim MJ, Song SY, Park SW, Cha SW, et al. Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 2009;250:110-17. doi: 10.1148/radiol.2493080226
17. Fraioli F, Anzidei M, Zaccagna F, Mennini ML, Serra G, Gori B, et al. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience. Radiology 2011;259:574-82. doi: 10.1148/radiol.11100600
18. Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 2012;13:239-46. doi: 10.1016/S1470-2045(11)70393-X
19. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evalutaion of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7. (Pubitemid 13129630)
20. Saddi KA, Chefd'hotel C, Cheriet F. Large deformation registration of contrastenhanced images with volume-preserving constraint. In: Pluim JPW, Reinhardt JM, editors. Proceedings of SPIE: Medical Imaging 2007 Image Processing, Vol 6512. Bellingham, WA: Spie-the International Society for Optical Engineering; 2007. p. 651203.
21. Li Y, Yang ZG, Chen TW, Deng YP, Yu JQ, Li ZL. Whole tumour perfusion of peripheral lung carcinoma: evaluation with first-pass CT perfusion imaging at 64-detector row CT. Clin Radiol 2008;63:629-35. doi: 10.1016/j. crad.2007.12.012
22. Miles KA, Lee TY, Goh V, Klotz E, Cuenod C, Bisdas S, et al. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol 2012;22: 1430-41. Epub 2012 Feb 26. doi: 10.1007/s00330-012-2379-4